DCOY
DCOY
NASDAQ · Biotechnology

Decoy Therapeutics Inc

$3.58
+0.05 (+1.42%)
As of Aug 14, 10:26 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,143.9% upside
Low Target $37.12
Average Target $44.53
High Target $63.68
Current Price $3.58
Current
$3.58
Target
$44.53
$37.12 $44.53 avg $63.68
Scenario Analysis
Bear Case
$37.12
936.9%
Low target
Base Case
$44.53
+1,143.9%
Avg target
Bull Case
$63.68
+1,678.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$106.20
-96.6% from high
52-Week Low
$3.51
+2.0% from low
Target vs 52W High
$44.53
-58.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%